RxDoctor Payments Data

Carla Davis

Pediatric Allergy/Immunology · Washington, DCNPI 1679653018

Payments from drug & device makers

$301,942in general payments, 2019–2025

Across 77 payments — averaging $3921.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$249K
  • AstraZeneca$34K
  • Genentech USA, Inc.$12K
  • Aimmune Therapeutics, Inc.$5K
  • Novartis$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$923
  • plus $449 from 6 others
$256in research payments, 2019–2025

Across 1 payment — averaging $255.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$256

What the payments were for

  • Consulting fees$9235%
  • Speaking & faculty fees$16,40086%
  • Travel & lodging$8815%
  • Food & beverage$8074%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric allergy/immunology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.

Other pediatric allergy/immunology in Washington

Where these figures come from

Is this you, or does something look wrong? →